Gareth Parkes

5.4k total citations · 1 hit paper
49 papers, 1.8k citations indexed

About

Gareth Parkes is a scholar working on Genetics, Epidemiology and Gastroenterology. According to data from OpenAlex, Gareth Parkes has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 24 papers in Epidemiology and 20 papers in Gastroenterology. Recurrent topics in Gareth Parkes's work include Inflammatory Bowel Disease (27 papers), Microscopic Colitis (22 papers) and Gastrointestinal motility and disorders (14 papers). Gareth Parkes is often cited by papers focused on Inflammatory Bowel Disease (27 papers), Microscopic Colitis (22 papers) and Gastrointestinal motility and disorders (14 papers). Gareth Parkes collaborates with scholars based in United Kingdom, United States and Italy. Gareth Parkes's co-authors include Jeremy Sanderson, Kevin Whelan, Miranda Lomer, Jonathan Brostoff, James O. Lindsay, Barry Hudspith, Neil B. Rayment, Liljana Petrovska, Julian Parkhill and Carol Churcher and has published in prestigious journals such as Gastroenterology, Gut and Scientific Reports.

In The Last Decade

Gareth Parkes

45 papers receiving 1.7k citations

Hit Papers

High-throughput clone library analysis of the mucosa-asso... 2011 2026 2016 2021 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease
    2011 561 citations Alan W. Walker, Jeremy Sanderson et al. BMC Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gareth Parkes United Kingdom 14 862 709 446 425 346 49 1.8k
Encarna Varela Spain 21 617 0.7× 1.3k 1.9× 331 0.7× 394 0.9× 309 0.9× 39 2.3k
Alba Santiago Spain 14 342 0.4× 1.2k 1.7× 317 0.7× 370 0.9× 180 0.5× 18 1.7k
Samuel P. Costello Australia 23 591 0.7× 1.1k 1.6× 525 1.2× 724 1.7× 434 1.3× 65 2.2k
Hannah Fehlner-Peach United States 8 362 0.4× 1.4k 1.9× 328 0.7× 367 0.9× 312 0.9× 8 2.2k
Jessica Y. L. Ching Hong Kong 26 410 0.5× 983 1.4× 421 0.9× 413 1.0× 781 2.3× 70 2.9k
Anne Bourrier France 18 933 1.1× 810 1.1× 167 0.4× 837 2.0× 428 1.2× 38 2.0k
Josie Libertucci Canada 12 343 0.4× 1.2k 1.7× 462 1.0× 440 1.0× 220 0.6× 15 1.7k
Helen Steed United Kingdom 14 388 0.5× 616 0.9× 245 0.5× 211 0.5× 322 0.9× 43 1.5k
Ramesh Paramsothy Australia 9 463 0.5× 1.3k 1.8× 488 1.1× 520 1.2× 284 0.8× 15 1.8k
Aleksandra Banaszkiewicz Poland 21 361 0.4× 253 0.4× 329 0.7× 347 0.8× 376 1.1× 105 1.3k

Countries citing papers authored by Gareth Parkes

Since Specialization
Citations

This map shows the geographic impact of Gareth Parkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gareth Parkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gareth Parkes more than expected).

Fields of papers citing papers by Gareth Parkes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gareth Parkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gareth Parkes. The network helps show where Gareth Parkes may publish in the future.

Co-authorship network of co-authors of Gareth Parkes

This figure shows the co-authorship network connecting the top 25 collaborators of Gareth Parkes. A scholar is included among the top collaborators of Gareth Parkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gareth Parkes. Gareth Parkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parkes, Gareth, Ayesha Akbar, Ian Beales, et al.. (2025). Health-related quality of life outcomes among vedolizumab-treated patients with inflammatory bowel disease in the UK and Ireland: a 52-week observational study (OCTAVO). Journal of Patient-Reported Outcomes. 9(1). 80–80.
2.
3.
Schreiber, Stefan, Remo Panaccione, Gareth Parkes, et al.. (2024). 984 RISANKIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 COMMAND STUDY. Gastroenterology. 166(5). S–238. 1 indexed citations
4.
Louis, Édouard, Remo Panaccione, Gareth Parkes, et al.. (2024). OP06 Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study. Journal of Crohn s and Colitis. 18(Supplement_1). i10–i12. 10 indexed citations
5.
Sulais, Eman Al, Édouard Louis, Bernd Bokemeyer, et al.. (2024). Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire. Journal of Crohn s and Colitis. 19(2). 2 indexed citations
6.
Peyrin‐Biroulet, Laurent, Gareth Parkes, Jesse Siffledeen, et al.. (2023). Tu1723 ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE BY NUMBER AND TYPE OF PRIOR BIOLOGICS. Gastroenterology. 164(6). S–1094. 1 indexed citations
7.
Feagan, Brian G., Gareth Parkes, Pascal Juillerat, et al.. (2023). P52 Benefits of high versus low dose upadacitinib as maintenance treatment in ulcerative colitis. Poster presentations. A72.2–A73. 1 indexed citations
8.
Parkes, Gareth, Ryan C. Ungaro, Silvio Danese, et al.. (2023). Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis. Journal of Gastroenterology. 58(10). 990–1002. 11 indexed citations
9.
Honap, Sailish, Gareth Parkes, Mark Samaan, et al.. (2021). P103 Ustekinumab: medium-term outcomes from a uk multi-centre real-world cohort. A94.2–A95. 1 indexed citations
10.
Fragkos, Konstantinos C., Sailish Honap, Louise Whiteley, et al.. (2020). P507 Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort. Journal of Crohn s and Colitis. 14(Supplement_1). S439–S440. 2 indexed citations
11.
12.
13.
Elliott, Timothy R., Neil B. Rayment, Barry Hudspith, et al.. (2015). Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn’s disease. BMC Gastroenterology. 15(1). 75–75. 14 indexed citations
14.
Parkes, Gareth, Kevin Whelan, & James O. Lindsay. (2014). Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect. Journal of Crohn s and Colitis. 8(8). 717–725. 183 indexed citations
15.
Parkes, Gareth, et al.. (2011). The probiotic VSL#3 increases scbm and reduces symptom severity scores in patients with functional constipation: Figure 1. Gut. 60(Suppl 1). A163.1–A163. 1 indexed citations
16.
Walker, Alan W., Jeremy Sanderson, Carol Churcher, et al.. (2011). High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiology. 11(1). 7–7. 561 indexed citations breakdown →
17.
Parkes, Gareth, Jeremy Sanderson, & Kevin Whelan. (2009). The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. The Lancet Infectious Diseases. 9(4). 237–244. 81 indexed citations
18.
Parkes, Gareth, Jonathan Brostoff, Kevin Whelan, & Jeremy Sanderson. (2008). Gastrointestinal Microbiota in Irritable Bowel Syndrome: Their Role in Its Pathogenesis and Treatment. The American Journal of Gastroenterology. 103(6). 1557–1567. 135 indexed citations
19.
Lomer, Miranda, Gareth Parkes, & Jeremy Sanderson. (2007). Review article: lactose intolerance in clinical practice – myths and realities. Alimentary Pharmacology & Therapeutics. 27(2). 93–103. 380 indexed citations
20.
Parkes, Gareth. (2007). An overview of probiotics and prebiotics. Nursing Standard. 21(20). 43–47. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Encarna Varela Breakdown of academic impact, for papers by Alba Santiago Breakdown of academic impact, for papers by Samuel P. Costello Breakdown of academic impact, for papers by Hannah Fehlner-Peach Breakdown of academic impact, for papers by Jessica Y. L. Ching Breakdown of academic impact, for papers by Anne Bourrier Breakdown of academic impact, for papers by Josie Libertucci Breakdown of academic impact, for papers by Helen Steed Breakdown of academic impact, for papers by Ramesh Paramsothy Breakdown of academic impact, for papers by Aleksandra Banaszkiewicz
Rankless by CCL
2026